inSoma Bio
PrivateLast Round
Accelerator
Jun 5, 2025
Est. Valuation
$1.79M
Total Funding Raised
$8.29M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
inSoma Bio operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was an Accelerator round in June 2025.
inSoma Bio is a biotechnology company that develops bioengineered reconstructive biomaterials for plastic and reconstructive surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
inSoma Bio Comparables
Compare inSoma Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempo Therapeutics, Inc. | 85% | |
| Regenyx Medical | 84% | |
| LifeSprout | 83% |
For institutional investors. Book with your work email.
inSoma Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 5, 2025 | ||||
| Seed | Nov 1, 2023 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Mar 31, 2023 | ||||
| Debt | Dec 15, 2022 | ||||
Grant | Dec 15, 2022 |
For institutional investors. Book with your work email.
inSoma Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Makai VC | Seed |
| MedBlue Incubator | Seed |
| Y Combinator | Pre Seed, Accelerator |
| North Carolina Biotechnology Center | Debt, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors grew 44% MoM.
- Apr 23, 2026
Monthly visitors increased 433% MoM.
For institutional investors. Book with your work email.
inSoma Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about inSoma Bio's valuation, stock price, and market status.
Is inSoma Bio a public or private company?
inSoma Bio is a private company.
What is the current stock price of inSoma Bio?
inSoma Bio is a private company, so its shares have no public market price. Caplight tracks inSoma Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is inSoma Bio worth (valuation)?
inSoma Bio's valuation is estimated at $1.8M based on funding round data.
Can I buy inSoma Bio stock?
inSoma Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was inSoma Bio's last funding round?
inSoma Bio's most recent funding round was Accelerator on June 5, 2025.
Who are the main investors in inSoma Bio?
Key investors in inSoma Bio include National Cancer Institute, MedTech Innovator, NIH RADx, Makai VC, MedBlue Incubator.
Will inSoma Bio IPO soon?
No public IPO plans have been announced for inSoma Bio.
How can I track inSoma Bio secondary market activity?
Caplight tracks bids, offers, and trades in inSoma Bio's shares on secondary markets.